Viglimet

Vildagliptin+Metformin
DPP-4 Inhibitor & Biguanide combination (Oral Antidiabetic)

Indication:
Management of type 2 diabetes mellitus.

Dosage & Administration:
Adults: Based on the patient's current dose of Metformin, Combination of Vildagliptin & Metformin may be initiated at either 50 mg/500 mg or 50 mg/850 mg twice daily, 1 tab in the morning and the other in the evening. The recommended daily dose is 100 mg Vildagliptin plus 2000 mg Metformin HCl. Patients receiving Vildagliptin and Metformin from separate tablets may be switched to Combination of Vildagliptin & Metformin containing the same doses of each component. Doses higher than 100 mg of Vildagliptin are not recommended. There is no clinical experience of Vildagliptin and Metformin in triple combination with other antidiabetic agents. Taking Combination of Vildagliptin & Metformin with or just after food may reduce gastrointestinal symptoms associated with Metformin.

Preparation:
ViglimetTM 50/500 Tablet: Each box contains 30 tablets in blister pack.
ViglimetTM 50/850 Tablet: Each box contains 30 tablets in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides